NASDAQ:CLBS - Caladrius Biosciences News Headlines

Sign in or create an account to add this stock to your watchlist.
$3.00 -0.01 (-0.33 %)
(As of 05/27/2019 06:00 AM ET)
Previous Close$3.00
Today's Range$2.95 - $3.01
52-Week Range$2.77 - $11.65
Volume2,943 shs
Average Volume24,351 shs
Market Capitalization$31.14 million
P/E RatioN/A
Dividend YieldN/A
Beta1.75

Headlines

Caladrius Biosciences (NASDAQ CLBS) News Headlines

Source:
DateHeadline
Caladrius Biosciences Inc (CLBS) Receives Average Rating of "Buy" from AnalystsCaladrius Biosciences Inc (CLBS) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - May 14 at 12:32 PM
Caladrius Biosciences (CLBS) Research Coverage Started at WBB SecuritiesCaladrius Biosciences (CLBS) Research Coverage Started at WBB Securities
www.americanbankingnews.com - May 14 at 10:43 AM
Caladrius Biosciences (CLBS) Rating Reiterated by Chardan CapitalCaladrius Biosciences (CLBS) Rating Reiterated by Chardan Capital
www.americanbankingnews.com - May 12 at 11:23 AM
Caladrius Biosciences (CLBS) Announces Quarterly  Earnings Results, Misses Estimates By $0.05 EPSCaladrius Biosciences (CLBS) Announces Quarterly Earnings Results, Misses Estimates By $0.05 EPS
www.americanbankingnews.com - May 11 at 1:23 PM
Edited Transcript of CLBS earnings conference call or presentation 9-May-19 8:30pm GMTEdited Transcript of CLBS earnings conference call or presentation 9-May-19 8:30pm GMT
finance.yahoo.com - May 10 at 5:46 PM
Caladrius Biosciences Reports 2019 First Quarter Financial Results and Provides Corporate UpdateCaladrius Biosciences Reports 2019 First Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - May 9 at 5:56 PM
Caladrius Biosciences to Participate at the Upcoming May ConferencesCaladrius Biosciences to Participate at the Upcoming May Conferences
finance.yahoo.com - May 7 at 5:52 PM
Caladrius Biosciences Inc (CLBS) Expected to Post Earnings of -$0.39 Per ShareCaladrius Biosciences Inc (CLBS) Expected to Post Earnings of -$0.39 Per Share
www.americanbankingnews.com - May 5 at 3:36 PM
Caladrius Biosciences (CLBS) Set to Announce Quarterly Earnings on ThursdayCaladrius Biosciences (CLBS) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - May 3 at 9:59 AM
Caladrius Biosciences to Host 2019 First Quarter Financial Results Conference Call on Thursday, MayCaladrius Biosciences to Host 2019 First Quarter Financial Results Conference Call on Thursday, May
www.nasdaq.com - May 2 at 9:59 AM
Caladrius Biosciences to Host 2019 First Quarter Financial Results Conference Call on Thursday, May 9, 2019 at 4:30 p.m. Eastern TimeCaladrius Biosciences to Host 2019 First Quarter Financial Results Conference Call on Thursday, May 9, 2019 at 4:30 p.m. Eastern Time
finance.yahoo.com - May 2 at 9:59 AM
How Does Caladrius Biosciences, Inc. (NASDAQ:CLBS) Affect Your Portfolio Volatility?How Does Caladrius Biosciences, Inc. (NASDAQ:CLBS) Affect Your Portfolio Volatility?
finance.yahoo.com - April 25 at 5:58 PM
Caladrius Biosciences to Participate in Upcoming ConferencesCaladrius Biosciences to Participate in Upcoming Conferences
finance.yahoo.com - April 3 at 8:59 AM
Form 424B5 CALADRIUS BIOSCIENCES, - StreetInsider.comForm 424B5 CALADRIUS BIOSCIENCES, - StreetInsider.com
www.streetinsider.com - March 21 at 5:43 PM
Caladrius Biosciences, Inc. Estimate MomentumCaladrius Biosciences, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 5:47 PM
Caladrius Biosciences, Inc.: Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial ResultsCaladrius Biosciences, Inc.: Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial Results
www.finanznachrichten.de - March 15 at 10:27 AM
Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q4 2018 Earnings Conference Call TranscriptCaladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q4 2018 Earnings Conference Call Transcript
seekingalpha.com - March 15 at 10:27 AM
Caladrius Biosciences announces Purchase Agreement with Lincoln Park Capital for up to $26 millionCaladrius Biosciences announces Purchase Agreement with Lincoln Park Capital for up to $26 million
finance.yahoo.com - March 14 at 5:52 PM
Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial ResultsCaladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial Results
finance.yahoo.com - March 14 at 5:52 PM
Caladrius Biosciences to Present at the Alliance for Regenerative Medicine 7th Annual Cell & Gene Therapy Investor Day - GlobeNewswireCaladrius Biosciences to Present at the Alliance for Regenerative Medicine 7th Annual Cell & Gene Therapy Investor Day - GlobeNewswire
globenewswire.com - March 12 at 11:51 AM
Caladrius Biosciences to Present at the Alliance for Regenerative Medicine 7th Annual Cell & Gene Therapy Investor DayCaladrius Biosciences to Present at the Alliance for Regenerative Medicine 7th Annual Cell & Gene Therapy Investor Day
finance.yahoo.com - March 11 at 5:36 PM
What Kind Of Shareholder Appears On The Caladrius Biosciences, Inc.’s (NASDAQ:CLBS) Shareholder Register?What Kind Of Shareholder Appears On The Caladrius Biosciences, Inc.’s (NASDAQ:CLBS) Shareholder Register?
finance.yahoo.com - March 11 at 5:36 PM
Caladrius down 23% on disappointing CLBS03 dataCaladrius down 23% on disappointing CLBS03 data
seekingalpha.com - February 14 at 5:31 PM
The Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage TrialThe Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage Trial
www.benzinga.com - February 14 at 9:51 AM
Caladrius Biosciences Reports Top-Line Data for the Phase 2a Sanford Project: T-Rex Trial of CLBS03 for Recent Onset Type 1 DiabetesCaladrius Biosciences Reports Top-Line Data for the Phase 2a Sanford Project: T-Rex Trial of CLBS03 for Recent Onset Type 1 Diabetes
finance.yahoo.com - February 13 at 5:32 PM
Caladrius Biosciences to Present at Upcoming February ConferencesCaladrius Biosciences to Present at Upcoming February Conferences
finance.yahoo.com - February 5 at 8:31 AM
What Makes Caladrius Biosciences (CLBS) a New Buy StockWhat Makes Caladrius Biosciences (CLBS) a New Buy Stock
www.zacks.com - January 23 at 9:21 AM
Caladrius Biosciences to Participate in Upcoming January ConferencesCaladrius Biosciences to Participate in Upcoming January Conferences
finance.yahoo.com - January 7 at 8:36 AM
Caladrius Biosciences Inc.Caladrius Biosciences Inc.
www.barrons.com - December 27 at 5:28 PM
Recent Analysis Shows Escalade, Caladrius Biosciences, LightInTheBox Holding Co., Vishay Intertechnology ...Recent Analysis Shows Escalade, Caladrius Biosciences, LightInTheBox Holding Co., Vishay Intertechnology ...
globenewswire.com - November 15 at 5:25 PM
Caladrius Biosciences, Inc. 2018 Q3 - Results - Earnings Call SlidesCaladrius Biosciences, Inc. 2018 Q3 - Results - Earnings Call Slides
seekingalpha.com - November 14 at 5:25 PM
BRIEF-Caladrius Biosciences Reports Q3 Loss Per Share Of $0.36 From Continuing OperationsBRIEF-Caladrius Biosciences Reports Q3 Loss Per Share Of $0.36 From Continuing Operations
www.msn.com - November 9 at 8:42 AM
Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q3 2018 Earnings Conference Call TranscriptCaladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q3 2018 Earnings Conference Call Transcript
seekingalpha.com - November 9 at 8:42 AM
Caladrius Biosciences to Participate in the Inv€$tival Showcase in Partnership with Jefferies and the Jefferies 2018 London Healthcare ConferenceCaladrius Biosciences to Participate in the Inv€$tival Showcase in Partnership with Jefferies and the Jefferies 2018 London Healthcare Conference
finance.yahoo.com - November 9 at 8:42 AM
Caladrius Biosciences Reports 2018 Third Quarter Financial ResultsCaladrius Biosciences Reports 2018 Third Quarter Financial Results
finance.yahoo.com - November 8 at 5:23 PM
Caladrius Biosciences Appoints Cynthia Schwalm to Board of DirectorsCaladrius Biosciences Appoints Cynthia Schwalm to Board of Directors
finance.yahoo.com - November 8 at 8:45 AM
Caladrius Biosciences to Host Third Quarter 2018 Financial Results Conference Call on Thursday, November 8, 2018 at 4:30 p.m. ETCaladrius Biosciences to Host Third Quarter 2018 Financial Results Conference Call on Thursday, November 8, 2018 at 4:30 p.m. ET
finance.yahoo.com - November 2 at 9:10 AM
Caladrius Biosciences Inc (NASDAQ:CLBS): How Does It Impact Your Portfolio?Caladrius Biosciences Inc (NASDAQ:CLBS): How Does It Impact Your Portfolio?
finance.yahoo.com - October 1 at 5:08 PM
Caladrius Biosciences to Participate in Upcoming October ConferencesCaladrius Biosciences to Participate in Upcoming October Conferences
finance.yahoo.com - September 27 at 8:14 AM
Caladrius Biosciences: Cheap With Catalysts On The WayCaladrius Biosciences: Cheap With Catalysts On The Way
seekingalpha.com - September 24 at 9:13 AM
Caladrius Biosciences (CLBS) Shares March Higher, Can It Continue?Caladrius Biosciences (CLBS) Shares March Higher, Can It Continue?
finance.yahoo.com - September 21 at 5:08 PM
Is Caladrius Biosciences (CLBS) Stock Outpacing Its Medical Peers This Year?Is Caladrius Biosciences (CLBS) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - September 12 at 5:02 PM
Caladrius Biosciences to Present at the 20th Annual Rodman & Renshaw Global Investment ConferenceCaladrius Biosciences to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
globenewswire.com - August 30 at 5:23 PM
Caladrius Biosciences Reports 2018 Second Quarter and First Six Months Financial ResultsCaladrius Biosciences Reports 2018 Second Quarter and First Six Months Financial Results
finance.yahoo.com - August 9 at 5:18 PM
Caladrius Biosciences to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 9, 2018 at 4:30 p.m. ETCaladrius Biosciences to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 9, 2018 at 4:30 p.m. ET
finance.yahoo.com - August 2 at 9:01 AM
Caladrius Biosciences (CLBS) Granted FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory AnginaCaladrius Biosciences (CLBS) Granted FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina
www.streetinsider.com - June 22 at 8:37 AM
Benzingas Daily Biotech Pulse: AbbVie Launches New Pediatric Humira, IPO Deluge Hits The StreetBenzinga's Daily Biotech Pulse: AbbVie Launches New Pediatric Humira, IPO Deluge Hits The Street
www.msn.com - June 21 at 9:30 AM
Caladrius Spikes on FDA NodCaladrius Spikes on FDA Nod
www.baystreet.ca - June 20 at 5:35 PM
Caladrius Shares Extend Rally After FDA Grants Special Status To Cell TherapyCaladrius Shares Extend Rally After FDA Grants Special Status To Cell Therapy
feeds.benzinga.com - June 20 at 11:39 AM
Caladrius Bio up 25% premarket on accelerated review status in U.S. for CD34+ cell therapyCaladrius Bio up 25% premarket on accelerated review status in U.S. for CD34+ cell therapy
seekingalpha.com - June 19 at 9:58 AM
This page was last updated on 5/27/2019 by MarketBeat.com Staff

Featured Article: Fundamental Analysis

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel